Cargando…
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
BACKGROUND: Lupus nephritis (LN) is a common and serious complication of systemic lupus erythematosus. Anti-double-stranded (ds) DNA immunoglobulin G (IgG) plays a pivotal role in the pathogenesis of LN. Currently, there are various therapies for patients with LN; however, most of them are associate...
Autores principales: | Wang, Huixia, Lu, Mei, Zhai, Siyue, Wu, Kunyi, Peng, Lingling, Yang, Jie, Xia, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889545/ https://www.ncbi.nlm.nih.gov/pubmed/31791413 http://dx.doi.org/10.1186/s13075-019-2038-0 |
Ejemplares similares
-
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019) -
Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
Publicado: (1991) -
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
por: Keil, Andreas, et al.
Publicado: (2016) -
Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022) -
Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)